On May 30, 2018 Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep
understanding of the human immune response, reported that John A. Orwin, President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Wednesday, June 6, 2017 at 2:30 p.m. Eastern Time in New York, NY. Mr. Orwin will provide an overview of Atreca’s technologies, programs and progress (Press release, Atreca, MAY 30, 2018, View Source [SID1234526987]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!